---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-21-016698"
form_type: "8-K"
ticker: "AYTU"
cik: "0001385818"
company_name: "AYTU BIOPHARMA, INC"
filed_at: "2021-12-13T23:59:59+00:00"
generated_at: "2026-06-28T01:37:15.443073+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# CFO Richard Eisenstadt resigns effective Dec 30, 2021; successor search underway

## Summary
- Richard I. Eisenstadt resigns as CFO effective Dec 30, 2021 to pursue opportunity at another development-stage pharma.
- Resignation not due to any disagreements with Company's operations, policies, practices, or auditors.
- Company has initiated a search to identify and recruit a new CFO; CEO Josh Disbrow signing the filing.
- No interim CFO named; current CFO to depart at month-end.

## SEC filing metadata
- accession: 0001558370-21-016698
- form_type: 8-K
- ticker: AYTU
- cik: 0001385818
- company_name: AYTU BIOPHARMA, INC
- filed_at: 2021-12-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1385818/000155837021016698/0001558370-21-016698-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1385818/000155837021016698/aytu-20211208x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-21-016698
- JSON: https://secwatch.observer/filing/0001558370-21-016698.json
- Plain text: https://secwatch.observer/filing/0001558370-21-016698.txt

## Key facts
- Executive change
  Richard I. Eisenstadt resigned as Chief Financial Officer at AYTU BIOPHARMA, INC.
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On December 8, 2021, Richard I. Eisenstadt resigned as Chief Financial Officer of Aytu BioPharma, Inc. (the “Company”), effective December 30, 2021, to pursue another opportunity at a development-stage pharmaceutical company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1385818/000155837021016698/0001558370-21-016698-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.